The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Open accessPublished version of a preprint
Abstract
Background/Aims: Patients with cirrhosis and hepatocellular carcinoma (HCC) require extensive and personalized care to improve outcomes. ChatGPT (Generative Pre-trained Transformer), a large language model, holds the potential to provide professional yet patient-friendly support. We aimed to examine the accuracy and reproducibility of ChatGPT in answering questions regarding knowledge, management, and emotional support for cirrhosis and HCC.Methods: ChatGPT’s responses to 164 questions were independently graded by two transplant hepatologists and resolved by a third reviewer. The performance of ChatGPT was also assessed using two published questionnaires and 26 questions formulated from the quality measures of cirrhosis management. Finally, its emotional support capacity was tested.Results: We showed that ChatGPT regurgitated extensive knowledge of cirrhosis (79.1% correct) and HCC (74.0% correct), but only small proportions (47.3% in cirrhosis, 41.1% in HCC) were labeled as comprehensive. The performance was better in basic knowledge, lifestyle, and treatment than in the domains of diagnosis and preventive medicine. For the quality measures, the model answered 76.9% of questions correctly but failed to specify decision-making cut-offs and treatment durations. ChatGPT lacked knowledge of regional guidelines variations, such as HCC screening criteria. However, it provided practical and multifaceted advice to patients and caregivers regarding the next steps and adjusting to a new diagnosis.Conclusions: We analyzed the areas of robustness and limitations of ChatGPT’s responses on the management of cirrhosis and HCC and relevant emotional support. ChatGPT may have a role as an adjunct informational tool for patients and physicians to improve outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0186-y · Cited by 4,228
Self-citationTraining language models to follow instructions with human feedback
Ouyang, L., Wu, J., Jiang, X., Almeida, D., Wainwright, C. L., Mishkin, P., Zhang, C., Agarwal, S., Slama, K., Ray, A., et al. (2022) · arXiv · doi:10.48550/arxiv.2203.02155 · Cited by 4,208
Global burden of primary liver cancer in 2020 and predictions to 2040
Rumgay, H., Arnold, M., Ferlay, J., Lesi, O., Cabasag, C. J., Vignat, J., Laversanne, M., McGlynn, K. A., & Soerjomataram, I. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.021 · Cited by 2,197
Epidemiology of Hepatocellular Carcinoma
McGlynn, K. A., Petrick, J. L., & El‐Serag, H. B. (2021) · Hepatology · doi:10.1002/hep.31288 · Cited by 2,147
Gilson, A., Safranek, C. W., Huang, T., Socrates, V., Chi, L., Taylor, R. A., & Chartash, D. (2023) · JMIR Medical Education · doi:10.2196/45312 · Cited by 2,078
Tsochatzis, E. A., Bosch, J., & Burroughs, A. K. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60121-5 · Cited by 1,740
Sepanlou, S. G., Safiri, S., Bisignano, C., Ikuta, K. S., Merat, S., Saberifiroozi, M., Poustchi, H., Tsoi, D., Colombara, D. V., Abdoli, A., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30349-8 · Cited by 1,714 · cited 1×
“4% of worldwide deaths related to cirrhosis.(1) Cirrhosis is a major risk factor for hepatocellular carcinoma (HCC), which has also demonstrated increased incidence and mortality in recent decades.”
BackgroundGinès, P., Krag, A., Abraldes, J. G., Solà, E., Fabrellas, N., & Kamath, P. S. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01374-x · Cited by 1,663
Deep reinforcement learning from human preferences
Christiano, P., Leike, J., Brown, T. B., Martic, M., Legg, S., & Amodei, D. (2017) · arXiv · doi:10.48550/arxiv.1706.03741 · Cited by 1,058 · cited 1×
“6 incorporating feedback and correction from human input, allowing it to generate more coherent and contextually appropriate responses.(22) This process is known as Reinforcement Learning from Human Feedback or Reinforcement Learning from Human Preference (RLHF/RLHP).”
BackgroundUpper Digestive Bleeding in Cirrhosis. Post–Therapeutic Outcome and Prognostic Indicators
D'Amico, G., & De Franchis, R. (2003) · Hepatology · doi:10.1053/jhep.2003.50385 · Cited by 907
ChatGPT makes medicine easy to swallow: an exploratory case study on simplified radiology reports
Jeblick, K., Schachtner, B., Dexl, J., Mittermeier, A., Stüber, A. T., Topalis, J., Weber, T., Wesp, P., Sabel, B. O., Ricke, J., et al. (2023) · European Radiology · doi:10.1007/s00330-023-10213-1 · Cited by 549
Structural interventions to reduce and eliminate health disparities
Brown, A. F., Ma, G. X., Miranda, J., Eng, E., Castille, D., Brockie, T., Jones, P., Airhihenbuwa, C. O., Farhat, T., Zhu, L., et al. (2019) · American Journal of Public Health · doi:10.2105/ajph.2018.304844 · Cited by 465 · cited 1×
“Enhancement of availability and ease of access to this resource could reduce health disparities, diminish disease burden, and improve the overall well-being of the population.(29) Furthermore, this increased accessibility can also reduce anxiety among patients and caregivers by providing access to real-time informatio…”
BackgroundNew advances in the diagnosis and management of hepatocellular carcinoma
Yang, J. D., & Heimbach, J. K. (2020) · BMJ · doi:10.1136/bmj.m3544 · Cited by 384
Self-citationCirrhosis and its complications: Evidence based treatment
Nusrat, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i18.5442 · Cited by 285
Guide for diagnosis and treatment of hepatocellular carcinoma
Attwa, M. H. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i12.1632 · Cited by 242
Farvardin, S., Patel, J., Khambaty, M., Yerokun, O. A., Mok, H., Tiro, J. A., Yopp, A. C., Parikh, N. D., Marrero, J. A., & Singal, A. G. (2017) · Hepatology · doi:10.1002/hep.28770 · Cited by 185
Gilson, A., Safranek, C., Huang, T., Socrates, V., Chi, L., Taylor, R. A., & Chartash, D. (2022) · doi:10.1101/2022.12.23.22283901 · Cited by 172
McAdam-Marx, C., McGarry, L. J., Hane, C. A., Biskupiak, J., Deniz, B., & Brixner, D. I. (2011) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2011.17.7.531 · Cited by 167
van Meer, S., de Man, R. A., Coenraad, M. J., Sprengers, D., van Nieuwkerk, K. M. J., Klümpen, H., Jansen, P. L. M., IJzermans, J. N. M., van Oijen, M. G. H., Siersema, P. D., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.012 · Cited by 139
Increasing Economic Burden in Hospitalized Patients With Cirrhosis: Analysis of a National Database
Desai, A. P., Mohan, P., Nokes, B. T., Sheth, D., Knapp, S. M., Boustani, M. A., Chalasani, N., Fallon, M. B., & Calhoun, E. A. (2019) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000062 · Cited by 117
Victora, C. G., Barros, A. J. D., de França, G. V. A., Crochemore‐Silva, I., Carvajal-Vélez, L., & Amouzou, A. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30077-3 · Cited by 80
Heydari, A., Ziaee, E. S., & Gazrani, A. (2015) · PubMed Central · Cited by 32
Health literacy levels in outpatients with liver cirrhosis
Grydgaard, M. F., & Bager, P. (2018) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2018.1545045 · Cited by 28
Limited Knowledge of Acetaminophen in Patients with Liver Disease
Saab, S., Konyn, P., Viramontes, M. R., Jimenez, M., Grotts, J. F., Hamidzadah, W., Dang, V. P., Esmailzadeh, N., Choi, G., Durazo, F. A., et al. (2016) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2016.00049 · Cited by 27
Health literacy and liver disease
Gulati, R., Nawaz, M., & Pyrsopoulos, N. (2018) · Clinical Liver Disease · doi:10.1002/cld.690 · Cited by 27
Hayward, K. L., Valery, P. C., Patel, P. J., Horsfall, L. U., Wright, P. L., Tallis, C. J., Stuart, K. A., David, M., Irvine, K. M., Cottrell, N., et al. (2020) · Internal Medicine Journal · doi:10.1111/imj.14986 · Cited by 25
Valery, P., Bernardes, C., Hayward, K., Hartel, G., Haynes, K., Gordon, L., Stuart, K., Wright, P. L., Johnson, A. L., & Powell, E. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02407-6 · Cited by 25
Health Literacy Gaps in Online Resources for Cirrhotic Patients
Kaundinya, T., Mazumder, N. R., Atiemo, K., Spellman, A., Daud, A., Curtis, L. M., & Ladner, D. P. (2020) · Journal of Current Surgery · doi:10.14740/jcs401 · Cited by 12
Research works printed but not linked: 1
- Noguchi, Therapy by chatbot? The promise and challenges in using AI for mental health
Cited by
Sallam, M. (2023) · Healthcare · doi:10.3390/healthcare11060887 · Cited by 3,126
“However, ChatGPT emulation of empathetic responses was reported in a preprint in the context of hepatic disease [74].”
BackgroundMethodInfluentialYenduri, G., Ramalingam, M., Selvi, G. C., Supriya, Y., Srivastava, G., Maddikunta, P. K. R., Raj, G. D., Jhaveri, R. H., Prabadevi, B., Wang, W., et al. (2024) · IEEE Access · doi:10.1109/access.2024.3389497 · Cited by 596
Utility of ChatGPT in Clinical Practice
Liu, J., Wang, C., & Liu, S. (2023) · Journal of Medical Internet Research · doi:10.2196/48568 · Cited by 505
Haltaufderheide, J., & Ranisch, R. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01157-x · Cited by 396
Lim, Z. W., Pushpanathan, K., Yew, S. M. E., Lai, Y., Sun, C.-H., Lam, J. S. H., Chen, D. Z., Goh, J. H. L., Tan, M. C. J., Sheng, B., et al. (2023) · eBioMedicine · doi:10.1016/j.ebiom.2023.104770 · Cited by 310
Metadata
- Authors
- Yeo, Y. H., Samaan, J. S., Ng, W. H., Ting, P.-S., Trivedi, H., Vipani, A., Ayoub, W., Yang, J. D., Liran, O., Spiegel, B., & Kuo, A.
- Venue
- Clinical and Molecular Hepatology
- Published
- 2023-07-01
- Volume
- 29
- Issue
- 3
- Pages
- 721-732
- ISSN
- 2287-2728 (ISSN-L)
- 2287-285X
- OpenAlex
- W4353016766
- Cited by
- 662
- References
- 28
- FWCI
- 22.77
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by-nc/3.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.